UCTT Ultra Clean Holdings, Inc. gains 17% Jul 31, 2017

Ultra Clean Holdings, Inc. designs, develops, prototypes, engineers, manufactures, and tests production tools, modules, and subsystems for the semiconductor capital equipment and equipment industry segments primarily in North America, Asia, and Europe. It offers precision robotic systems that are used when accurate controlled motion is required; gas delivery systems, which include one or more gas lines consisting of small diameter internally polished stainless steel tubing products, filters, mass flow controllers, regulators, pressure transducers and valves, component heaters, and an integrated electronic and/or pneumatic control system; and various industrial and automation production equipment products. The company also provides subsystems, such as wafer cleaning sub-systems; chemical delivery modules that deliver gases and reactive chemicals in a liquid or gaseous form from a centralized subsystem to the reaction chamber; frame assemblies, which are support structures fabricated from steel tubing or folded sheet metal; and top-plate assemblies. In addition, it offers liquid delivery systems; process modules, which are the subsystems of semiconductor manufacturing tools that process integrated circuits onto wafers; and other high level assemblies. The company primarily serves original equipment manufacturing customers in the semiconductor capital equipment, consumer, medical, energy, industrial, flat panel, and research industries. Ultra Clean Holding, Inc. was founded in 1991 and is headquartered in Hayward, California. http://www.priceseries.com/trade/UCTT-Ultra-Clean-Holdings-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017070720170731.html

TEAR TearLab Corporation gains 44% Jul 31, 2017

TearLab Corp. operates as an in-vitro diagnostic company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company's system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California. http://www.priceseries.com/trade/TEAR-TearLab-Corporation-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2017071820170731.html

HTZ Hertz Global Holdings, Inc gains 66% Jul 31, 2017

Hertz Global Holdings, Inc., an airport general use vehicle rental company, engages in the vehicle rental business in North America, Europe, Latin America, Africa, Asia, Australia, the Caribbean, the Middle East, and New Zealand. The company operates in three segments: U.S. RAC, International RAC, and All Other Operations. It offers vehicle rental services approximately from 1,600 airport rental locations and 2,600 off airport locations in the United States; and 1,400 airport rental locations and 4,100 off airport rental locations internationally to business and leisure customers. The company operates the Hertz, Dollar, and Thrifty vehicle rental brands in approximately 9,700 corporate and franchisee locations; and sells ancillary products and services. It also owns the vehicle leasing and fleet management business that operates the Firefly and Hertz 24/7 car sharing rental business in international markets; and sells vehicles through its Hertz Car Sales. As of December 31, 2016, the company operated a rental fleet of approximately 515,900 vehicles in the United States and 196,600 vehicles in international operations. Hertz Global Holdings, Inc. was founded in 1918 and is based in Estero, Florida. http://www.priceseries.com/trade/HTZ-Hertz-Global-Holdings-Inc-stock-gains-66-percent-a-Trade-Record-by-priceSeries-2017062320170731.html

HK Halcon Resources Corporation gains 44% Jul 31, 2017

Halcon Resources Corporation, an independent energy company, engages in the acquisition, production, exploration, and development of onshore oil and natural gas properties in the United States. The company primarily holds interests in approximately 116,000 net acres, as well as 300 producing wells in the Bakken/Three Forks formations in North Dakota; and 20,901 net acres in the Southern Delaware Basin in Pecos and Reeves Counties, Texas, as well as has an option to acquire approximately 15,040 net acres in Ward and Winkler Counties, Texas. As of December 31, 2016, it had estimated proved reserves of approximately 148.6 million barrels of oil equivalent comprising 119.6 million barrels of crude oil, 15.6 million barrels of natural gas liquids, and 80.2 billion cubic feet of natural gas. The company was formerly known as RAM Energy Resources, Inc. and changed its name to Halcon Resources Corporation in February 2012. Halcon Resources Corporation was founded in 1987 and is headquartered in Houston, Texas. http://www.priceseries.com/trade/HK-Halcon-Resources-Corporation-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2017071020170731.html

FLXN Flexion Therapeutics, Inc. gains 30% Jul 31, 2017

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. http://www.priceseries.com/trade/FLXN-Flexion-Therapeutics-Inc-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2017061920170731.html

CBAY Cymabay Therapeutics Inc. gains 19% Jul 31, 2017

Cymabay Therapeutics, Inc. focuses on developing therapies to treat metabolic diseases. Its key clinical development candidates comprise MBX-8025, a selective agonist that is in a third Phase II clinical trial in patients with primary biliary cholangitis; and Arhalofenate, which completed five Phase II clinical trials for the treatment of gout. The company's product candidate also includes MBX-2982, an oral, G-protein coupled receptor agonist to treat type II diabetes. Cymabay Therapeutics, Inc. has a development and license agreements with Janssen Pharmaceuticals, Inc. to develop and discover undisclosed metabolic disease target agonists for the treatment of type II diabetes and other disorders; and a license and development agreement with DiaTex, Inc. to develop and commercialize therapeutic products. The company was formerly known as Metabolex, Inc. Cymabay Therapeutics, Inc. was incorporated in 1988 and is based in Newark, California. http://www.priceseries.com/trade/CBAY-Cymabay-Therapeutics-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2017071720170731.html

CAR Avis Budget Group, Inc. gains 37% Jul 31, 2017

Avis Budget Group, Inc., together with its subsidiaries, provides car and truck rentals, car sharing, and ancillary services to businesses and consumers worldwide. The company operates through two segments: Americas and International. It operates the Avis brand car rental system with approximately 5,550 locations that supply rental cars to the premium commercial and leisure segments of the travel industry; the Budget brand vehicle rental system with approximately 4,050 car rental locations, which serve the value-conscious segments of the industry; and the Zipcar brand, a membership-based car sharing network that provides vehicles to approximately 1 million members. The company also operates the Payless brand, which comprises approximately 240 vehicle rental locations; the Apex brand primarily in the deep-value segment of the car rental industry with approximately 25 rental locations in New Zealand and Australia; and the Maggiore brand that provides vehicle rental services in the commercial, leisure, and insurance replacement/leasing segments with approximately 130 rental locations in Italy, as well as the France Cars brand, which offers light commercial vehicle fleets with approximately 60 rental locations in France. In addition, it is involved in the local and one-way truck rental businesses with a fleet of approximately 22,000 vehicles, which are rented through a network of approximately 1,000 dealers and 480 company-operated locations that serve the consumer and light commercial sectors in the continental United States. Further, the company provides a range of optional insurance products and coverages, such as supplemental liability, personal accident, personal effects protection, emergency sickness protection, automobile towing protection, and cargo insurance products. Avis Budget Group, Inc. was founded in 1946 and is headquartered in Parsippany, New Jersey. http://www.priceseries.com/trade/CAR-Avis-Budget-Group-Inc-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2017062220170731.html

VRTX Vertex Pharmaceuticals Incorporated gains 16% Jul 28, 2017

Vertex Pharmaceuticals Incorporated discovers, develops, manufactures, and commercializes medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs. It markets ORKAMBI (lumacaftor in combination with ivacaftor) for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 2 years of age and older who have the G551D mutation or other specified mutations in their CFTR gene. The company also develops Tezacaftor (VX-661), a corrector compound that is in a Phase III development program in combination with ivacaftor in multiple CF patients; VX-152 and VX-440 that are CFTR corrector compounds in Phase II clinical trials, as well as VX-659 and VX-445 that are CFTR corrector compounds in Phase I clinical trials; and VX-371, an investigational epithelial sodium channel, which is in a Phase II development program. In addition, it engages in the research and mid-and early-stage development programs in the areas of oncology, pain, and neurology. The company sells its products primarily to specialty pharmacy providers and wholesalers in North America, as well as government-owned and supported customers internationally. Vertex Pharmaceuticals Incorporated has collaborations with Cystic Fibrosis Foundation Therapeutics Incorporated; Parion Sciences, Inc.; CRISPR Therapeutics AG; Moderna Therapeutics, Inc.; BioAxone Biosciences, Inc.; Merck KGaA; and Janssen Pharmaceuticals, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts. http://www.priceseries.com/trade/VRTX-Vertex-Pharmaceuticals-Incorporated-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017071820170728.html

PRXL PAREXEL International Corporation gains 37% Jul 28, 2017

PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market development, product development, and targeted communications services in the support of product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions, such as spirometry, electronic clinical outcomes, and wearables. The company was founded in 1983 and is headquartered in Waltham, Massachusetts. http://www.priceseries.com/trade/PRXL-PAREXEL-International-Corporation-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2017042720170728.html

COHU Cohu, Inc. gains 15% Jul 28, 2017

Cohu, Inc., through its subsidiaries, engages in the development, manufacture, sale, and servicing of semiconductor test and inspection handlers, micro-electro mechanical system (MEMS) test modules, test contactors, and thermal sub-systems for semiconductor manufacturers and test subcontractors worldwide. It offers pick-and-place handlers; thermal handler for microprocessors, graphics processors, and other integrated circuits; pick-and-place platform for fabless and outsourced semiconductor assembly and test customers, as well as for integrated device manufacturers; a platform for assembly automation; gravity-feed and test-in-strip handlers; and turret handler for testing and inspection of integrated circuits, LEDs, and discrete devices. The company also provides MEMS test modules that generate physical stimuli for testing of sensor integrated circuits; thermal sub-systems that offer temperature control of the integrated circuit during the testing process; contactor solutions; spares; and a range of device dedication kits that enable handlers to process various semiconductor packages. Cohu, Inc. markets its products through direct sales force and independent sales representatives. The company was formerly known as Cohu Electronics, Inc. and changed its name to Cohu, Inc. in 1972. Cohu, Inc. was founded in 1947 and is headquartered in Poway, California. http://www.priceseries.com/trade/COHU-Cohu-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017071020170728.html

WTW Weight Watchers International Inc gains 21% Jul 27, 2017

Weight Watchers International, Inc. provides weight management services worldwide. The company operates in four segments: North America, United Kingdom, Continental Europe, and Other. It offers a range of products and services comprising nutritional, activity, behavioral, and lifestyle tools and approaches. The company also engages in the meetings business, which presents weight management programs, as well as allows members to support each other by sharing their experiences with other people experiencing similar weight management challenges. In addition, it offers various digital subscription products, including Weight Watchers OnlinePlus and a weight management companion for Weight Watchers meeting members to digitally manage the day-to-day aspects of their weight management plan, as well as provides interactive and personalized resources that allow users to follow weight management plan. Further, the company provides Personal Coaching, an online subscription product that offers one-on-one telephonic, e-mail, and text support and personalized planning from a Weight Watchers-certified coach, as well as offers access to other online tools. Additionally it offers various products, including bars, snacks, cookbooks, food, and restaurant guides with SmartPoints values, Weight Watchers magazines, SmartPoints calculators, and fitness kits, as well as third-party products, such as activity-tracking monitors. The company also licenses the Weight Watchers brand and other intellectual property in frozen foods, baked goods, and other consumer products, as well as endorses selected branded consumer products; and engages in publishing magazines, as well issues other publications, such as cookbooks, and food and restaurant guides with SmartPoints values. It offers products through its meeting and franchisee business, as well as online. Weight Watchers International, Inc. was founded in 1961 and is headquartered in New York, New York. http://www.priceseries.com/trade/WTW-Weight-Watchers-International-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2017061920170727.html

RELV Reliv; International, Inc. gains 19% Jul 27, 2017

Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. It offers approximately 17 nutritional supplements, primarily including Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri. http://www.priceseries.com/trade/RELV-Reliv;-International-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2017071820170727.html

QURE uniQure N.V. gains 45% Jul 27, 2017

uniQure N.V., a biopharmaceutical company, engages in the discovery, development, and commercialization of gene therapies in the Netherlands. The company offers Glybera, a gene therapy product for the treatment of patients with lipoprotein lipase deficiency. It is also developing AMT-060, a gene therapy that is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-110, a gene therapy that has been completed Phase I/II clinical trial for the treatment of sanfilippo B syndrome; AAV2/glial cell line-derived neurotrophic factor, which is in Phase I clinical trial for the treatment of parkinson's disease; S100A1, a preclinical product candidate for the treatment of congestive heart failure; AMT-130 for the treatment of huntington's disease; and AAV5 for the treatment of hemophilia A. The company has collaborations with Bristol-Myers Squibb Company, 4D Molecular Therapeutics, Treeway B.V., Chiesi Farmaceutici S.p.A. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands. http://www.priceseries.com/trade/QURE-uniQure-NV-stock-gains-45-percent-a-Trade-Record-by-priceSeries-2017062120170727.html

QBAK Qualstar Corporation gains 64% Jul 27, 2017

Qualstar Corporation designs, develops, manufactures, and sells power supplies under the N2Power brand; and data storage systems under the Qualstar brand worldwide. It offers switching power supplies that are used to convert AC line voltage to DC voltages, or DC voltages to other DC voltages for use in electronic equipment, such as telecommunications equipment, machine tools, routers, switches, wireless systems, and gaming devices. The company also provides automated magnetic tape libraries used to store, retrieve, and manage electronic data primarily in network computing environments, as well as provide data storage solutions for organizations requiring backup, recovery, and archival storage of critical data. Its tape libraries include cartridge tape drives, tape cartridges, and robotics that move the cartridges from their storage locations to the tape drives under software control. The company serves original equipment manufacturers, information technology departments, and small and medium businesses through distributor and reseller network, distributors, and independent outside sales representatives. Qualstar Corporation was founded in 1984 and is headquartered in Simi Valley, California. http://www.priceseries.com/trade/QBAK-Qualstar-Corporation-stock-gains-64-percent-a-Trade-Record-by-priceSeries-2017070720170727.html

OZM Och-Ziff Capital Management Group LLC gains 16% Jul 27, 2017

Och-Ziff Capital Management Group LLC is a publicly owned hedge fund sponsor. The firm provides investment advisory services for its clients. It primarily caters to institutional investors which include pension funds, fund-of-funds, foundations and endowments, corporations and other institutions, private banks and family offices. The firm invests in equity and alternative markets across the world. It employs quantitative and qualitative analysis to make its investments. For its multi-strategy portfolios, the firm employs strategies like convertible and derivative arbitrage, corporate credit, long/short equity special situations, buyout investments, merger arbitrage, private investments, and structured credit. It also invests in real estate and traditional real estate assets including multifamily, office, hotel and retail, loans, portfolio acquisitions, loan pools, operating companies, structured debt products, public securities, and non-traditional real estate assets including gaming, distressed land and residential, cell towers, parking, golf, debt and senior housing. For private equity investments, it considers investments in a variety of special situations that seek to realize value through strategic sales or initial public offerings. The firm typically invests in the energy investments. It prefers to invest in United States. It also manages a buyout fund, Och-Ziff Energy Fund. Och-Ziff Capital Management Group LLC was founded in 1994 and is based New York City with additional offices in Houston, Texas, London, United Kingdom, Hong Kong, Tokyo, Japan, Bangalore, India, Singapore, and Beijing, China. http://www.priceseries.com/trade/OZM-Och-Ziff-Capital-Management-Group-LLC-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017063020170727.html

NTP Nam Tai Property Inc. gains 23% Jul 27, 2017

Nam Tai Property Inc. engages in the property development and management activities in the People's Republic of China. It focuses on developing two parcels of land for converting into commercial complexes in Gushu and Guangming, Shenzhen. The company was formerly known as Nam Tai Electronics, Inc. and changed its name to Nam Tai Property Inc. in April 2014. Nam Tai Property Inc. was founded in 1975 and is headquartered in Shenzhen, the People's Republic of China. http://www.priceseries.com/trade/NTP-Nam-Tai-Property-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2017071020170727.html

MITK Mitek Systems, Inc. gains 17% Jul 27, 2017

Mitek Systems, Inc. develops, markets, and sells mobile capture and identity verification software solutions for enterprise customers worldwide. The company applies its patented technology in image capture, correction, and intelligent data extraction in the mobile financial and business services markets. Its technology allows users to remotely deposit checks, open accounts, get insurance quotes, and pay bills, as well as verify their identity by taking pictures of various documents with their camera-equipped smartphones and tablets instead of using the device keyboard. The company offers Mobile Fill to pre-fill forms with personal data by simply snapping a picture of the consumer's driver license, credit card, or other document; Mobile Verify, an identity verification solution that can be integrated into mobile apps, mobile Websites, and desktop applications; and Mobile Docs, a mobile document scanning solution. It also provides Mobile Deposit, a software that allows users to remotely deposit a check using their camera-equipped smartphones or tablets; and Commercial Mobile Deposit Capture product that integrates the same core technology as Mobile Deposit with additional capabilities specific to small and medium size businesses. The company markets and sells its solutions primarily to financial services, such as banks, credit unions, lenders, payments processers, card issuers, insurers, etc. through direct sales teams and channel partners. Mitek Systems, Inc. was founded in 1983 and is headquartered in San Diego, California. http://www.priceseries.com/trade/MITK-Mitek-Systems-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017070720170727.html

HZNP Horizon Pharma plc gains 18% Jul 27, 2017

Horizon Pharma Public Limited Company, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases in the United States and internationally. The company's marketed medicine portfolio consists of ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; RAVICTI and BUPHENYL/AMMONAPS to treat urea cycle disorders; PROCYSBI for the treatment of nephropathic cystinosis; QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients; and KRYSTEXXA to treat chronic refractory gout. Its products also include RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and multiple other indications; DUEXIS to treat signs and symptoms of osteoarthritis and rheumatoid arthritis; MIGERGOT for the treatment of vascular headache; PENNSAID 2% to treat pain of osteoarthritis of the knees; and VIMOVO for the treatment of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The company has collaboration agreements with Fox Chase Cancer Center to study ACTIMMUNE in combination with PD-1/PD-L1 inhibitors for use in the treatment of various forms of cancer; and Alliance for Lupus Research (ALR) to study the effect of RAYOS on the fatigue experienced by systemic lupus erythematosus (SLE) patients. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland. http://www.priceseries.com/trade/HZNP-Horizon-Pharma-plc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2017062020170727.html

HQCL Hanwha Q CELLS Co., Ltd. gains 17% Jul 27, 2017

Hanwha Q CELLS Co., Ltd., a solar energy company, develops, manufactures, and sells solar cells and photovoltaic (PV) modules in the United States, Europe, South Korea, Japan, the People's Republic of China, India, Turkey, and internationally. Its principal products include PV cells, PV modules, silicon ingots, and silicon wafers. The company also develops and builds solar power projects, and sells them to third-party purchasers; and offers engineering, procurement, and construction, as well as operation and management services comprising inspections, repair and replacement of plant equipment, site management, and administrative support services. It serves solar power system integrators and distributors through third party distributors. The company is headquartered in Seoul, South Korea. Hanwha Q CELLS Co., Ltd. operates as a subsidiary of Hanwha Solar Holdings Co., Ltd. http://www.priceseries.com/trade/HQCL-Hanwha-Q-CELLS-Co-Ltd--stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017071220170727.html

EXEL Exelixis, Inc. gains 22% Jul 27, 2017

Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. The company's products include CABOMETYX for the treatment of patients with advanced renal cell carcinoma, who have received prior anti-angiogenic therapy; and COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid carcinoma. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development program. It also offers COTELLIC (cobimetinib), a selective inhibitor of MEK, in combination with vemurafenib for the treatment of patients with BRAF V600E or V600K mutation-positive advanced melanoma in the United States; and in combination with vemurafenib in other territories, including the European Union, Switzerland, Canada, Australia, and Brazil. Exelixis, Inc. has collaboration and license agreements with Ipsen Pharma SAS, Genentech, Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Sanofi, Merck, and Daiichi Sankyo Company Limited for the development and commercialization of various compounds and programs. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California. http://www.priceseries.com/trade/EXEL-Exelixis-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2017061920170727.html

DRRX Durect Corporation gains 44% Jul 27, 2017

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and drug delivery programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for use as raw materials for pharmaceutical and medical devices under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in clinical development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase 1 development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival. The company's advanced oral, injectable, and transdermal delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs, including POSIMIR, an investigational analgesic product intended to deliver bupivacaine to provide up to 3 days of pain relief after surgery; and REMOXY ER, an investigational extended release pain relief drug. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has collaboration agreements with Santen Pharmaceutical Co., Ltd.; Impax Laboratories, Inc.; Zogenix, Inc.; and Pain Therapeutics, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California. http://www.priceseries.com/trade/DRRX-Durect-Corporation-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2017061220170727.html

ARNA Arena Pharmaceuticals, Inc. gains 56% Jul 27, 2017

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for various therapeutic areas in the United States and Switzerland. The company's proprietary investigational clinical programs include etrasimod (APD334), which is in Phase IIb evaluation for ulcerative colitis, as well as is in Phase IIa evaluation for dermatologic extraintestinal manifestations in inflammatory bowel disease, pyoderma gangrenosum, and primary biliary cholangitis; ralinepag that is in Phase IIb evaluation to treat pulmonary arterial hypertension; and APD371, which is in Phase IIa evaluation for the treatment of pain associated with Crohn's disease. It has collaboration agreements with Eisai Inc.; Eisai Co., Ltd.; Axovant Sciences Ltd.; and Boehringer Ingelheim International GmbH. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California. http://www.priceseries.com/trade/ARNA-Arena-Pharmaceuticals-Inc-stock-gains-56-percent-a-Trade-Record-by-priceSeries-2017062620170727.html

AGEN Agenus Inc. gains 35% Jul 27, 2017

Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, and LAG-3. In addition, the company develops vaccine programs, such as Prophage cancer vaccine candidate; AutoSynVax, a synthetic cancer vaccine program targeting the neo-epitope landscape in cancer patients; and PhosPhoSynVax, a vaccine candidate designed to induce immunity against a novel class of tumor specific neo-epitopes. Further, Agenus Inc. develops QS-21 Stimulon, a saponin-based vaccine adjuvant that has completed Phase III clinical trials for the treatment of malaria and shingles. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. http://www.priceseries.com/trade/AGEN-Agenus-Inc-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2017061920170727.html

AA Alcoa Inc. gains 17% Jul 27, 2017

Alcoa Corporation produces and sells bauxite, alumina, and aluminum products. It operates through six segments, Bauxite, Alumina, Aluminum, Cast Products, Energy, and Rolled Products. The company also offers aluminum cast products; and aluminum sheets for the production of cans for beverage, food, and pet food. In addition, it engages in the generation and sale of renewable energy, as well as provision of ancillary services. The company was formerly known as Alcoa Upstream Corporation and changed its name to Alcoa Corporation in October 2016. Alcoa Corporation is based in New York, New York. http://www.priceseries.com/trade/AA-Alcoa-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017062320170727.html

SVA Sinovac Biotech, Ltd. gains 27% Jul 26, 2017

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against hepatitis A, hepatitis B, seasonal influenza, H5N1 and H1N1 pandemic influenza, and mumps in the People's Republic of China. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine; and Split viron pandemic influenza vaccine. The company also develops the EV71 vaccine, which has completed Phase III clinical trial. In addition, it has completed pre-clinical studies for varicella, sabin inactivated polio, and hepatitis A and B vaccines; and focuses on commencing clinical trials for pneumococcal polysaccharide vaccine, pneumococcal conjugate vaccine, and rubella vaccine. The company has a collaboration agreement with GlaxoSmithKline Biologicals SA to develop combination vaccines containing measles for the China market; Tianjin CanSino Biotechnology Inc. to develop a pneumococcal conjugate vaccine; and a license agreement with Medimmune, LLC to use patented reverse genetics technology pertaining to H5N1 influenza virus strain production for vaccines. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China. http://www.priceseries.com/trade/SVA-Sinovac-Biotech-Ltd-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2017061420170726.html

SCHN Schnitzer Steel Industries, Inc. gains 27% Jul 26, 2017

Schnitzer Steel Industries, Inc. recycles ferrous and nonferrous scrap metals; and manufactures finished steel products worldwide. It operates through two segments, Auto and Metals Recycling (AMR) and Steel Manufacturing Business (SMB). The AMR segment buys, collects, processes, recycles, sells, and brokers scrap metals, as well as processes mixed and large pieces of scrap metal into smaller pieces by crushing, torching, shearing, shredding, and sorting. This segment offers ferrous scrap metal, a feedstock used in the production of finished steel products; and nonferrous products, including aluminum, copper, stainless steel, nickel, brass, titanium, lead, high temperature alloys, and joint products. It sells ferrous and nonferrous recycled metal products to steel mills, foundries, and smelters. This segment also procures salvaged vehicles and sells serviceable used auto parts from these vehicles through its 52 self-service auto parts stores in the United States and Western Canada, as well as sells auto bodies and parts containing ferrous and nonferrous materials, such as engines, transmissions, and alternators to wholesalers. The SMB segment produces various finished steel products using recycled metal and other raw materials. It offers semi-finished goods, which include billets; and finished goods consisting of rebar, coiled rebar, wire rods, merchant bars, and other specialty products. This segment serves steel service centers, construction industry subcontractors, steel fabricators, wire drawers, and farm and wood products suppliers. Schnitzer Steel Industries, Inc. was founded in 1906 and is headquartered in Portland, Oregon. http://www.priceseries.com/trade/SCHN-Schnitzer-Steel-Industries-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2017062220170726.html

GPRK Geopark Ltd gains 16% Jul 26, 2017

GeoPark Limited engages in the exploration, development, and production of oil and gas reserves in Chile, Colombia, Brazil, and Argentina. As of December 31, 2015, the company had working and/or economic interests in 33 hydrocarbons blocks, as well as shallow-offshore concession in Brazil that includes the Manati Field. It had net proved reserves of 48.6 million barrels of oil equivalent. The company was formerly known as GeoPark Holdings Limited and changed its name to GeoPark Limited in July 2013. GeoPark Limited was founded in 2002 and is based in Santiago, Chile. http://www.priceseries.com/trade/GPRK-Geopark-Ltd-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017070620170726.html

BOLD Audentes Therapeutics Inc gains 17% Jul 26, 2017

Audentes Therapeutics, Inc., a biotechnology company, focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects in the United States. The company is developing four products, including AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia; and AT982 for the treatment of pompe disease. Audentes Therapeutics, Inc. has a collaboration with the University of Pennsylvania to develop AT342, an AAV gene therapy for Crigler-Najjar Syndrome, an inherited, metabolic liver disease. The company was founded in 2012 and is based in San Francisco, California. http://www.priceseries.com/trade/BOLD-Audentes-Therapeutics-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017062120170726.html

AMTD TD Ameritrade Holding Corporation gains 19% Jul 26, 2017

TD Ameritrade Holding Corporation provides securities brokerage services and related technology-based financial services to retail investors, traders, and independent registered investment advisors (RIAs) in the United States. Its products and services include tdameritrade.com, a Web platform for self-directed retail investors; Trade Architect, a Web-based platform for investors and traders to identify opportunities and stay informed; thinkorswim, a desktop platform for traders; and TD Ameritrade Mobile, which allows on-the-go investors and traders to trade and monitor accounts. The company also offers TD Ameritrade Institutional that provides brokerage and custody services to approximately 5,000 independent RIAs and their clients; TD Ameritrade's Goal Planning, which offers investment consulting and planning services; Investools, a suite of investor education products and services for stock, option, foreign exchange, futures, mutual fund, and fixed-income investors; Amerivest, an advisory service that develops portfolios of exchange-traded funds (ETFs) and mutual funds; AdvisorDirect, a national referral service for investors; and TD Ameritrade Corporate Services that provide self-directed brokerage services to employees of corporations. In addition, it offers various retail brokerage products and services, such as common and preferred stocks; ETFs; options; futures; foreign exchange; mutual funds; fixed income products; primary and secondary offerings of fixed income securities, closed-end funds, and preferred stocks; margin lending; cash management services; and annuities. The company provides its services primarily through the Internet, a network of retail branches, mobile trading applications, interactive voice response, and registered representatives through telephone. TD Ameritrade Holding Corporation was founded in 1971 and is headquartered in Omaha, Nebraska. http://www.priceseries.com/trade/AMTD-TD-Ameritrade-Holding-Corporation-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2017060820170726.html

AGRX Agile Therapeutics, Inc. gains 18% Jul 26, 2017

Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey. http://www.priceseries.com/trade/AGRX-Agile-Therapeutics-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2017071220170726.html

POWI Power Integrations, Inc. gains 18% Jul 25, 2017

Power Integrations, Inc. designs, develops, and markets analog and mixed-signal integrated circuits, and other electronic components and circuitry used in high-voltage power conversion. The company offers a range of alternating current to direct current (DC) power conversion products that address power supply ranging from less than 1 watt of output to approximately 500 watts of output for mobile-device chargers, consumer appliances, utility meters, LCD monitors, main and standby power supplies for desktop computers and TVs, LED lamps, and other consumer and industrial applications. It also provides high-voltage diodes; and high-voltage gate-driver products under the SCALE and SCALE-2 product-family names. In addition, the company offers monolithic high-voltage DC-DC power conversion ICs designed for use in power-over-Ethernet powered devices, such as voice-over-IP phones and security cameras, as well as network hubs, line cards, servers, digital PBX phones, and DC-DC converter modules and industrial controls. Power Integrations, Inc. serves communications, computer, consumer, and industrial markets. The company sells its products to original equipment manufacturers and merchant power supply manufacturers directly, as well as through a network of independent sales representatives and distributors worldwide. Power Integrations, Inc. was founded in 1988 and is headquartered in San Jose, California. http://www.priceseries.com/trade/POWI-Power-Integrations-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2017062320170725.html

ABEO Abeona Therapeutics Inc. gains 78% Jul 25, 2017

Abeona Therapeutics Inc. focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company's lead programs are ABO-101 (AAV NAGLU) and ABO-102 (AAV SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA). It is also developing ABO-201 (AAV CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV FANCC) for Fanconi anemia (FA) disorder using a novel CRISPR/Cas9-based gene editing approach to gene therapy program for rare blood diseases. In addition, the company is developing rare plasma protein therapies, including PTB-101 SDF Alpha (alpha-1 protease inhibitor) for inherited COPD using its proprietary SDF (Salt Diafiltration) ethanol-free process. Further, it is involved in marketing MuGard, a mucoadhesive oral wound rinse, for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse, for the treatment of rectal mucositis and radiation proctitis. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1989 and is based in Dallas, Texas. http://www.priceseries.com/trade/ABEO-Abeona-Therapeutics-Inc-stock-gains-78-percent-a-Trade-Record-by-priceSeries-2017062120170725.html

YUMA Yuma Energy, Inc. gains 15% Jul 24, 2017

Yuma Energy, Inc., an oil and gas company, engages in the acquisition, exploration, and development of conventional and unconventional oil and gas properties primarily through the use of 3-D seismic surveys in the United States. It focuses on onshore central and southern Louisiana, targeting the Austin Chalk, Tuscaloosa, Wilcox, Frio, Marg Tex, and Hackberry formations. The company also has a non-operated position in the Bakken Shale in North Dakota; and operated positions in Kern and Santa Barbara Counties in California. As of December 31, 2015, it had proved reserves of approximately 13.3 million barrels of oil equivalent. The company is based in Houston, Texas. http://www.priceseries.com/trade/YUMA-Yuma-Energy-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017071220170724.html

WOR Worthington Industries, Inc. gains 16% Jul 24, 2017

Worthington Industries, Inc., a metals manufacturing company, focuses on value-added steel processing and manufactured metal products in the United States, Europe, Mexico, Canada, and internationally. The company operates through Steel Processing, Pressure Cylinders, Engineered Cabs, and Other segments. The Steel Processing segment processes flat-rolled steel for customers primarily in the automotive, aerospace, agricultural, appliance, construction, container, hardware, HVAC, lawn and garden, leisure and recreation, and office furniture and equipment markets. It also toll processes steel for steel mills, large end-users, service centers, and other processors; and designs and manufactures reusable custom steel platforms, racks, and pallets for supporting, protecting, and handling products in the shipping process for customers in industries, such as automotive, lawn and garden, and recreational vehicles. The Pressure Cylinders segment manufactures and sells filled and unfilled pressure cylinders, tanks, hand torches, oil and gas equipment, and various accessories and related products for a range of end-use market applications, including industrial products, consumer products, alternative fuels, oil and gas equipment, and cryogenics. The Engineered Cabs segment designs and manufactures custom-engineered open and enclosed cabs, as well as operator stations and custom fabrications for heavy mobile equipment used in agricultural, construction, forestry, military, and mining industries; and machined structural components, complex and painted weldments, engine doors, boom components, and complete frames. The Other segment develops energy solutions for entities in North America and Asia. Worthington Industries, Inc. was founded in 1955 and is headquartered in Columbus, Ohio. http://www.priceseries.com/trade/WOR-Worthington-Industries-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017062220170724.html

PMTS CPI Card Group Inc. gains 25% Jul 24, 2017

CPI Card Group Inc., together with its subsidiaries, engages in the design, production, data personalization, packaging, and fulfillment of financial payment cards. The company operates in three segments: U.S. Debit and Credit, U.S. Prepaid Debit, and U.K. Limited. The U.S. Debit and Credit segment produces financial payment cards and provides integrated card services to card-issuing banks in the United States. Its products include EMV and non-EMV credit cards, debit cards, and prepaid debit cards issued on the networks of the payment card brands, as well as private label credit cards and instant issuance systems. This segment also provides various integrated card services, including card personalization and fulfillment services, and instant issuance services. The U.S. Prepaid Debit segment primarily provides integrated card services comprising tamper-evident security packaging services, and card personalization and fulfillment services to prepaid debit card issuers in the United States. This segment also produces financial payment cards issued on the networks of the payment card brands. The U.K. Limited segment primarily produces retail gift and loyalty cards for customers in the United Kingdom and Europe. This segment also provides card personalization, packaging, and fulfillment services. CPI Card Group Inc. markets its products and services to national and regional banks, independent community banks, credit unions, managers of prepaid programs, group service providers, and card processors through field-based sales representatives in North America, Western Europe, the United Kingdom, and Canada. The company was formerly known as CPI Holdings I, Inc. and changed its name to CPI Card Group Inc. in August 2015. The company was founded in 2007 and is based headquartered in Littleton, Colorado. http://www.priceseries.com/trade/PMTS-CPI-Card-Group-Inc-stock-gains-25-percent-a-Trade-Record-by-priceSeries-2017062620170724.html

LILA Liberty Global plc gains 20% Jul 24, 2017

Liberty Global plc, together with its subsidiaries, provides video, broadband Internet, fixed-line telephony, mobile, and other communications services to residential customers and businesses internationally. It offers video services, including digital video programming and audio services starting with a basic video service, video-on-demand, electronic programming guide, various premium channel packages, digital video recorders, various mobile applications, set-top boxes, and pay-per-view programming. The company provides entertainment, sports, movies, documentaries, lifestyles, news, adult, children, and ethnic and foreign channels. It also offers Wi-Fi and Internet services, such as email, address book, and parental controls; security; online storage solutions and Web spaces; and Connect Box, a connectivity device that delivers in-home Wi-Fi coverage. In addition, the company provides multi-featured and circuit-switched telephony services; and mobile services comprising voice, short message service, and Internet access. Further, it offers voice, broadband Internet, data, video, wireless, and cloud services to small or home offices, small businesses, and medium and large enterprises, as well as on a wholesale basis to other operators. Liberty Global plc was founded in 2004 and is based in London, the United Kingdom. http://www.priceseries.com/trade/LILA-Liberty-Global-plc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2017062320170724.html

GILT Gilat Satellite Networks Ltd. gains 21% Jul 24, 2017

Gilat Satellite Networks Ltd., together with its subsidiaries, provides broadband satellite communication, and networking solutions and services worldwide. The company designs, manufactures, and provides network management and equipment for satellite communication (Satcom), as well as professional services. Its equipment consists of very small aperture terminals, solid-state power amplifiers, block up converters, low-profile antennas, and on-the-move/on-the-pause terminals. In addition, the company offers various solutions, including fully managed Satcom, satellite capacity, remote network operation, call center support, hub and field operations, and build operate transfer of rural communication networks. It sells its products and solutions to communication service providers and operators, mobile network operators, and system integrators, as well as to defense and homeland security organizations, and directly to end-users. The company has a strategic partnership with Air Esurfing to provide in-flight connectivity for China's domestic airline market; and a strategic collaboration with SES S.A. to focus on delivering affordable connectivity to a range of small ships and vessels left underserved at sea in the Caribbean and beyond. Gilat Satellite Networks Ltd. was founded in 1987 and is headquartered in Petah Tikva, Israel. http://www.priceseries.com/trade/GILT-Gilat-Satellite-Networks-Ltd-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2017062720170724.html

DRYS DryShips Inc. gains 18% Jul 24, 2017

DryShips Inc. owns and operates ocean going cargo vessels worldwide. It operates through two segments, Drybulk and Offshore Support. The Drybulk segment offers drybulk commodities transportation services for the steel, electric utility, construction, and agri-food industries. The Offshore Support segment provides its services to the global offshore energy industry. As of March 10, 2017, the company owned a fleet of 13 Panamax drybulk carriers with a combined deadweight tonnage of approximately 1.0 million tons; 1 very large crude carrier and 1 Aframax tanker newbuilding; 2 very large gas carrier newbuildings; and 6 offshore support vessels comprising 2 platform supply and 4 oil spill recovery vessels. DryShips Inc. was founded in 2004 and is based in Athens, Greece. http://www.priceseries.com/trade/DRYS-DryShips-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2017072120170724.html

BSET Bassett Furniture Industries, Incorporated gains 16% Jul 24, 2017

Bassett Furniture Industries, Incorporated manufactures, markets, and retails home furnishings in the United States. The company operates in three segments: Wholesale, Retail, and Logistical Services. It is involved in the design, manufacture, sourcing, sale, and distribution of furniture products to a network of company-owned and licensee-owned Bassett Home Furnishings (BHF) retail stores, as well as independent furniture retailers; and wood and upholstery operations. As of March 10, 2017, the company operated a network of 90 stores, including 59 company-owned and 31 licensee-owned stores. It also provides shipping, delivery, and warehousing services to customers in the furniture industry. In addition, the company owns and leases retail store properties. It also distributes its products through other multi-line furniture stores, Bassett galleries or design centers, specialty stores, and mass merchants. Bassett Furniture Industries was founded in 1902 and is based in Bassett, Virginia. http://www.priceseries.com/trade/BSET-Bassett-Furniture-Industries-Incorporated-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017062720170724.html

BGNE BeiGene, Ltd. gains 73% Jul 24, 2017

BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops molecularly-targeted and immuno-oncology drugs for the treatment of cancer. The company's clinical stage drug candidates include BGB-3111, a small molecule BTK inhibitor for the treatment of various lymphomas; BGB-283, a small molecule RAF dimer inhibitor to treat cancers with aberrations in the mitogen-activated protein kinase pathway, including BRAF mutations and KRAS/NRAS gene mutations; BGB-290, an inhibitor of PARP1 and PARP2 for the treatment of homologous recombination deficient cancers; and BGB-A317, a humanized monoclonal antibody for solid-organ and blood-borne cancers. Its preclinical programs comprise a PD-L1 monoclonal antibody, an additional RAF dimer inhibitor, a TIM-3 cell surface protein monoclonal antibody, and a BTK inhibitor for non-oncology indications. The company was founded in 2010 and is based in Camana Bay, the Cayman Islands. http://www.priceseries.com/trade/BGNE-BeiGene-Ltd-stock-gains-73-percent-a-Trade-Record-by-priceSeries-2017061620170724.html

SID National Steel Company gains 21% Jul 21, 2017

Companhia Siderurgica Nacional operates as an integrated steel producer in Brazil. It operates through five segments: Steel, Mining, Logistics, Cement, and Energy. It offers flat steel; slabs; hot-rolled products, including heavy and light-gauge hot-rolled coils and sheets; cold-rolled products comprising cold-rolled coils and sheets; galvanized sheets and coils; tin mill products that consist of flat-rolled low-carbon steel coils or sheets; profiles, sections, channels, UPE sections, and steel sleepers; and long steel products. The company primarily explores for iron ore reserves at Casa de Pedra mine located in the city of Congonhas in the state of Minas Gerais, Brazil. It sells iron ore products in Asia, Europe, and Brazil. The company also engages in logistics business comprising railway and port facilities; produces and sells cement; and generates electric power from its thermoelectric co-generation and hydroelectric power plants. The company also exports its products. Companhia Siderurgica Nacional was founded in 1941 and is headquartered in Sao Paulo, Brazil. Companhia Siderurgica Nacional operates as a subsidiary of Vicunha Acos S.A. http://www.priceseries.com/trade/SID-National-Steel-Company-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2017062320170721.html

INAP Internap Corporation gains 18% Jul 21, 2017

Internap Corporation operates as a technology provider of Internet infrastructure services. It operates through two business segments, Data Center and Network Services, and Cloud and Hosting Services. The Data Center and Network Services segment offers colocation services, including physical space within data centers and related services, such as power, interconnection, environmental controls, monitoring, and security; and Internet protocol (IP) connectivity services comprising its patented Performance IP and content delivery network services, IP routing hardware and software platforms, and Managed Internet Route Optimizer controllers. This segment offers its colocation services through 49 data centers in North America, Europe, and the Asia-Pacific region; and IP connectivity services through 81 IP service points worldwide. The Cloud and Hosting Services segment provides hosted Infrastructure-as-a-Service as a cloud platform or through managed hosting that includes the provision and maintenance of hardware, data center infrastructure, and interconnection that enables its customers to own and manage their software applications and content. This segment offers cloud and managed hosting services, which comprise compute and storage services, as well as a single tenant infrastructure environment through an integrated platform that includes servers, storage, and network. The company serves various industries, including software and Internet, such as advertising technology; media and entertainment comprising gaming; business services; hosting and IT infrastructure; health care technology infrastructure; and telecommunications. The company was formerly known as Internap Network Services Corporation and changed its name to Internap Corporation in November 2014. Internap Corporation was founded in 1996 and is headquartered in Atlanta, Georgia. http://www.priceseries.com/trade/INAP-Internap-Corporation-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2017062320170721.html

GGB Gerdau S.A. gains 20% Jul 21, 2017

Gerdau S.A. provides steel-related products and services worldwide. The company operates through Brazil Operations, North America Operations, South America Operations, and Special Steel Operations. It offers semi-finished products, such as billets, blooms, and slabs; common long rolled products, including rebars, merchant bars, and profiles that are used by the construction and manufacturing industries; and drawn products consisting of barbed and barbless fence wire, galvanized wire, fences, concrete reinforcing wire mesh, nails, and clamps, as well as mines and produces iron ore. It also produces special steel products for use in auto parts, light and heavy vehicles, and agricultural machinery, as well as oil and gas, wind energy, machinery and equipment, mining and rail, and others markets. In addition, it provides Flat Products, such as hot rolled coils and heavy plates; and resells flat steel products. The company sells its products through independent distributors, direct sales from the mills, and its retail network. The company was founded in 1901 and is based in Porto Alegre, Brazil. http://www.priceseries.com/trade/GGB-Gerdau-SA-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2017062220170721.html

CVM Cel-Sci Corporation gains 31% Jul 21, 2017

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. Multikine is also being used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company, through its LEAPS technology, provides peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia. http://www.priceseries.com/trade/CVM-Cel-Sci-Corporation-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2017062320170721.html

ARIS ARI Network Services, Inc. gains 35% Jul 21, 2017

ARI Network Services, Inc. provides software-as-a-service, data-as-a-service, and other solutions to equipment manufacturers, distributors, and dealers. Its solutions enable selling and servicing of new and used inventory, and parts, garments, and accessories (PG&A) for customers in the automotive tire and wheel aftermarket, automotive aftermarket parts and service, power sports, outdoor power equipment, marine, home medical equipment, recreational vehicles, and appliance industries. The company offers eCommerce-enabled Websites that provide consumers with information about a dealership and its product lines, and allow consumers to obtain information on whole goods and purchase PG&A through the dealers' Website, as well as provides mobile inventory management applications, third-party inventory integrations, and business management integrations. It also offers eCatalog platform solutions, such as PartSmart Web, which offers streamlined user experience, dynamic diagram thumbnail previews, and fast moving parts tracking and display; DataSmart that provides product data extract access and on-demand application programming interface access, which offer flexibility for implementation with various eCommerce software and search engine optimization (SEO) customization capabilities; AccessoryStream, which helps in the search engine ranking of parts, garments, and apparel products on Website; and OEM parts authoring software. In addition, the company provides business management software solutions; digital marketing services, including SEO, email marketing, social media management, search engine marketing, online reputation management, and online directory management through a suite of data-driven software tools; and a suite of complementary solutions that comprise software, Website customization services, professional services, and hosting services. ARI Network Services, Inc. was founded in 1981 and is headquartered in Milwaukee, Wisconsin. http://www.priceseries.com/trade/ARIS-ARI-Network-Services-Inc-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2017052520170721.html

OTIC Otonomy, Inc. gains 45% Jul 20, 2017

Otonomy, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear in the United States. It offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. The company also develops OTO-104, sustained-exposure formulation of the steroid dexamethasone in Phase III clinical trial for the treatment of Ménière's disease and other inner ear conditions; and OTO-311, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in a Phase 1 clinical safety trial for the treatment of tinnitus. Otonomy, Inc. was founded in 2008 and is headquartered in San Diego, California. http://www.priceseries.com/trade/OTIC-Otonomy-Inc-stock-gains-45-percent-a-Trade-Record-by-priceSeries-2017060820170720.html

OSUR OraSure Technologies, Inc. gains 20% Jul 20, 2017

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HIV1/2, OraQuick HIV self-test, OraQuick HCV, OraQuick In-Home HIV test, OraQuick Ebola, OraQuick Zika, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, OMNIgene GUT, OMNIgene SPUTUM, PrepIT MAX, OMNIgene VAGINAL, OMNIgene ORAL, PrepIT, Intercept, MICRO-PLATE DOA assays, Intercept i2, homogeneous DOA assays, and professional and over-the-counter cryosurgical systems. In addition, the company offers oral fluid collection devices to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, pharmacogenomics, personalized medicine, microbiome and animal genetics, and academic research markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, retail pharmacies, mass merchandisers, and consumers. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania. http://www.priceseries.com/trade/OSUR-OraSure-Technologies-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2017062220170720.html